Cells were cultured in vitro in increasing concentrations of either cisplatin or carboplatin until an increase in IC50 between two and ten-fold was achieved to reflect the resistance observed in human patients
Cellosaurus ID:
CVCL_E5FR
Parental cell line:
Ovsaho cell line
Model description:
Platinum-resistant HGSC in vivo cell line
Cat. #:
161763
Provenance and Ownership:
The OvsahoCis Cell Line is owned by Cancer Research UK. CancerTools supplies the OvsahoCis Cell Line under licence from Cancer Research UK and is the authorised source for its distribution. Sourcing OvsahoCis Cell Line directly from the IP owner ensures authenticity, provenance and compliance with all applicable licensing and research use requirements.
Cancer types:
Ovarian cancer
Research Fields:
Cancer
Organism:
Human
Tissue:
Ovary
Gender:
Female
Model:
Mutant
Growth properties:
Adherent
Primary citation:
J I Hoare et al. 2022. Gynecol Oncol. 167(1):96-106. PMID: 35918200.
Growth medium:
RPMI containing 10% FBS and 1% penicillin/streptomycin. Cells should be cultured without drug but used at low passage to ensure drug resistance is maintained.
Temperature:
37° C
Mycoplasma free:
Yes
References:
J I Hoare et al. 2022. Gynecol Oncol. 167(1):96-106. PMID: 35918200
Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.
